Budd-Chiari Syndrome in a Patient with Hepatitis C

Joseph Frankl1, Charles Hennemeyer2, Michael S Flores3

  • 1University of Arizona College of Medicine, Tucson, AZ 85724, USA.

Insights

Budd-Chiari syndrome, a liver disease, can mimic other chronic liver conditions. This case highlights its identification during a procedure for cirrhosis, emphasizing the need to consider secondary causes of portal hypertension.

Area of Science:

  • Hepatology
  • Vascular Medicine
  • Interventional Radiology

Background:

  • Chronic Budd-Chiari syndrome can present with cirrhosis, mimicking other chronic liver diseases.
  • Portal hypertension management can be challenging, necessitating consideration of underlying or coexisting conditions.
  • Hepatocellular carcinoma may coexist with other primary liver pathologies.

Purpose of the Study:

  • To report a case of Budd-Chiari syndrome initially misdiagnosed as hepatitis C-related cirrhosis.
  • To illustrate the successful management of Budd-Chiari syndrome with angioplasty.
  • To emphasize the importance of identifying secondary causes of portal hypertension.

Main Methods:

  • Transjugular intrahepatic portosystemic shunting (TIPS) attempted in a patient with decompensated cirrhosis.
  • Diagnosis of Budd-Chiari syndrome confirmed via venography, revealing hepatic venous webs.
  • Angioplasty performed to address hepatic venous webs and relieve portal hypertension.
  • Follow-up venography and liver biopsy to assess treatment efficacy and confirm etiology.

Main Results:

  • Budd-Chiari syndrome, caused by hepatic venous webs, was identified as the primary disease.
  • Angioplasty successfully resolved symptoms of portal hypertension.
  • Follow-up venography confirmed sustained patency of hepatic veins 5 months post-procedure.
  • Liver biopsy revealed centrilobular fibrosis, supporting venous occlusion as the cause of cirrhosis.

Conclusions:

  • Budd-Chiari syndrome should be considered in patients with difficult-to-manage portal hypertension, even with suspected alternative etiologies like hepatitis C.
  • Interventional radiology techniques, such as angioplasty, can effectively treat Budd-Chiari syndrome.
  • Accurate diagnosis of primary liver pathology is crucial for effective patient management and treatment outcomes.

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
883
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
730
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
313
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
457
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248